Smith & Nephew SNATS, Inc. (NYSE:SNN) was upgraded by equities research analysts at BidaskClub from a “hold” rating to a “buy” rating in a report released on Tuesday, August 1st.
Separately, Zacks Investment Research upgraded shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a report on Tuesday, July 11th. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $38.00.
Smith & Nephew SNATS (NYSE SNN) opened at 35.40 on Tuesday. Smith & Nephew SNATS has a one year low of $26.97 and a one year high of $36.05. The stock has a market capitalization of $15.50 billion, a price-to-earnings ratio of 18.02 and a beta of 0.76. The company’s 50-day moving average is $34.98 and its 200 day moving average is $33.17.
Several large investors have recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. increased its stake in shares of Smith & Nephew SNATS by 0.5% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 3,408 shares of the medical equipment provider’s stock worth $106,000 after buying an additional 17 shares in the last quarter. Greenleaf Trust purchased a new stake in shares of Smith & Nephew SNATS during the second quarter worth approximately $207,000. Paloma Partners Management Co purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth approximately $200,000. RMB Capital Management LLC purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth approximately $219,000. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in shares of Smith & Nephew SNATS during the first quarter worth approximately $224,000. 7.17% of the stock is currently owned by institutional investors.
Smith & Nephew SNATS Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.